Key result
Dual transfemoral TAVR and transseptal mitral ViV is feasible in an LVAD patient.
Case Report (n=1)
Demonstrates the feasibility of simultaneous transcatheter aortic and mitral valve-in-valve replacement in an LVAD patient.
Transcatheter aortic valve replacement is standard of care for patients with severe aortic stenosis at high risk for surgical aortic valve replacement. Although not intended for treatment of primary aortic insufficiency, several transcatheter aortic valve prostheses have been used to treat patients with severe aortic insufficiency (AI), including patients with left ventricular assist devices (LVAD), in whom significant AI is not uncommon. Similarly, transcatheter valve replacements have been used for valve-in-valve treatment, in the pulmonary, aortic, and mitral positions, either via a retrograde femoral approach or antegrade transseptal approach (mitral valve-in-valve). In this case report, we report an LVAD patient with severe aortic insufficiency and severe bioprosthetic mitral prosthetic stenosis, in whom we successfully performed transfemoral aortic valve replacement and transfemoral mitral valve-in-valve replacement via a transseptal approach.
No takes yet. Share an insight, caveat, or question.
Meduri et al. (2017) conducted a case report in Severe aortic insufficiency and severe bioprosthetic mitral prosthetic stenosis (n=1). Simultaneous transfemoral aortic valve replacement and transfemoral mitral valve-in-valve replacement via a transseptal approach was evaluated. Simultaneous transfemoral aortic valve replacement and transfemoral mitral valve-in-valve replacement via a transseptal approach was successfully performed in an LVAD patient.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: